AP2007004239A0 - Muscarinic acetycholine receptor antagonists - Google Patents

Muscarinic acetycholine receptor antagonists

Info

Publication number: AP2007004239A0
Authority: AP; ARIPO
Prior art keywords: receptor antagonists; acetycholine receptor; muscarinic; muscarinic acetycholine; antagonists
Prior art date: 2003-10-14

Application number

AP2007004239A

Other languages

English (en)

Inventor

Zehong Wan

Michael R Palovich

Jakob Busch-Petersen

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-14

Filing date

2004-10-12

Publication date

2007-12-31

2004-10-12 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2007-12-31 Publication of AP2007004239A0 publication Critical patent/AP2007004239A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AP2007004239A 2003-10-14 2004-10-12 Muscarinic acetycholine receptor antagonists AP2007004239A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51100903P	2003-10-14	2003-10-14
PCT/US2004/033638 WO2005037280A1 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists

Publications (1)

Publication Number	Publication Date
AP2007004239A0 true AP2007004239A0 (en)	2007-12-31

Family

ID=34465175

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AP2007004238A AP2007004238A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists
AP2007004239A AP2007004239A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists
AP2006003566A AP1828A (en)	2003-10-14	2004-10-12	Muscarinic Acetycholine receptor antagonists

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AP2007004238A AP2007004238A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AP2006003566A AP1828A (en)	2003-10-14	2004-10-12	Muscarinic Acetycholine receptor antagonists

Country Status (34)

Country	Link
US (3)	US7276521B2 (de)
EP (1)	EP1677795B1 (de)
JP (4)	JP2007508390A (de)
KR (3)	KR20080065318A (de)
CN (3)	CN101230062A (de)
AP (3)	AP2007004238A0 (de)
AR (1)	AR046103A1 (de)
AT (1)	ATE494285T1 (de)
AU (1)	AU2004281724B2 (de)
BR (1)	BRPI0415361A (de)
CA (1)	CA2542657C (de)
CY (1)	CY1111364T1 (de)
DE (1)	DE602004030930D1 (de)
DK (1)	DK1677795T3 (de)
EA (3)	EA013689B1 (de)
EC (1)	ECSP066468A (de)
ES (1)	ES2358673T3 (de)
HR (1)	HRP20110232T1 (de)
IL (2)	IL174843A0 (de)
IS (1)	IS2918B (de)
MA (1)	MA28110A1 (de)
MX (1)	MXPA06004244A (de)
MY (1)	MY143366A (de)
NO (1)	NO20062042L (de)
NZ (2)	NZ556424A (de)
OA (1)	OA13316A (de)
PE (1)	PE20050963A1 (de)
PL (1)	PL1677795T3 (de)
PT (1)	PT1677795E (de)
SG (1)	SG147436A1 (de)
SI (1)	SI1677795T1 (de)
TW (3)	TWI409060B (de)
UA (2)	UA87473C2 (de)
WO (1)	WO2005037280A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200519108A (en) *	2003-07-17	2005-06-16	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
KR20080065318A (ko) *	2003-10-14	2008-07-11	글락소 그룹 리미티드	무스카린성 아세틸콜린 수용체 길항제
CN1897947A (zh) *	2003-10-17	2007-01-17	葛兰素集团有限公司	蕈毒碱乙酰胆碱受体拮抗剂
TW200524577A (en) *	2003-11-04	2005-08-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
JP2007528420A (ja) *	2004-03-11	2007-10-11	グラクソ　グループ　リミテッド	新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
JP2007529511A (ja) *	2004-03-17	2007-10-25	グラクソ　グループ　リミテッド	Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
US7384946B2 (en) *	2004-03-17	2008-06-10	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
PE20060259A1 (es)	2004-04-27	2006-03-25	Glaxo Group Ltd	Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
US7598267B2 (en) *	2004-05-13	2009-10-06	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
WO2006055553A2 (en) *	2004-11-15	2006-05-26	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2007016639A2 (en) *	2005-08-02	2007-02-08	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
WO2007022351A2 (en) *	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
AU2007242851A1 (en)	2006-04-20	2007-11-01	Glaxo Group Limited	Novel compounds
GB0611587D0 (en)	2006-06-12	2006-07-19	Glaxo Group Ltd	Novel compounds
DK2046787T3 (da)	2006-08-01	2011-07-18	Glaxo Group Ltd	Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer
ATE547394T1 (de)	2006-12-01	2012-03-15	Bristol Myers Squibb Co	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
AR065804A1 (es)	2007-03-23	2009-07-01	Smithkline Beecham Corp	Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
EP2197444A1 (de) *	2007-09-12	2010-06-23	Glaxo Group Limited	Neue kombination von therapeutischen mitteln
AR070563A1 (es)	2008-02-06	2010-04-21	Glaxo Group Ltd	Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.
TW201000476A (en)	2008-02-06	2010-01-01	Glaxo Group Ltd	Dual pharmacophores-PDE4-muscarinic antagonistics
UY31635A1 (es)	2008-02-06	2009-08-31		Farmacóforos duales-antagonistas muscarínicos de pde4
US8163743B2 (en)	2008-06-05	2012-04-24	GlaxoGroupLimited	4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
ES2383246T3 (es)	2008-06-05	2012-06-19	Glaxo Group Limited	4-amino-indazoles
WO2010094643A1 (en)	2009-02-17	2010-08-26	Glaxo Group Limited	Quinoline derivatives and their uses for rhinitis and urticaria
WO2010097114A1 (en) *	2009-02-26	2010-09-02	Glaxo Group Limited	Novel combination of therapeutic agents
ES2739352T3 (es)	2009-02-26	2020-01-30	Glaxo Group Ltd	Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
JP5656880B2 (ja)	2009-03-09	2015-01-21	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
US8354539B2 (en)	2009-03-10	2013-01-15	Glaxo Group Limited	Indole derivatives as IKK2 inhibitors
EP2408769A1 (de)	2009-03-17	2012-01-25	Glaxo Group Limited	Als itk-inhibitoren verwendete pyrimidinderivate
MY160454A (en)	2009-04-30	2017-03-15	Glaxo Group Ltd	Oxazole substituted indazoles as pi3-kinase inhibitors
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
US20120245171A1 (en)	2009-12-03	2012-09-27	Glaxo Group Limited	Benzpyrazole derivatives as inhibitors of pi3 kinases
WO2011067364A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Novel compounds
WO2011067366A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Indazole derivatives as pi 3 - kinase inhibitors
WO2011110575A1 (en)	2010-03-11	2011-09-15	Glaxo Group Limited	Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
DK2614058T3 (en)	2010-09-08	2015-09-28	Glaxosmithkline Ip Dev Ltd	Polymorphs, and the salts of N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-yl] -2- (methyloxy) -3-pyridinyl] methanesulfonamide.
WO2012035055A1 (en)	2010-09-17	2012-03-22	Glaxo Group Limited	Novel compounds
GB201018124D0 (en)	2010-10-27	2010-12-08	Glaxo Group Ltd	Polymorphs and salts
ES2814336T3 (es)	2012-04-13	2021-03-26	Glaxosmithkline Ip Dev Ltd	Partículas de agregado
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
AU2014336251A1 (en)	2013-10-17	2016-04-14	Glaxosmithkline Intellectual Property Development Limited	PI3K inhibitor for treatment of respiratory disease
RU2016112268A (ru)	2013-10-17	2017-11-22	Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	Ингибитор PI3K для лечения респираторного заболевания
EA201692111A1 (ru)	2014-05-12	2017-08-31	Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед	Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
GB201602527D0 (en)	2016-02-12	2016-03-30	Glaxosmithkline Ip Dev Ltd	Chemical compounds
WO2018029126A1 (en)	2016-08-08	2018-02-15	Glaxosmithkline Intellectual Property Development Limited	Chemical compounds
GB201706102D0 (en)	2017-04-18	2017-05-31	Glaxosmithkline Ip Dev Ltd	Chemical compounds
GB201712081D0 (en)	2017-07-27	2017-09-13	Glaxosmithkline Ip Dev Ltd	Chemical compounds
JP2023519585A (ja)	2020-03-26	2023-05-11	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	ウイルス感染を予防または治療するカテプシン阻害剤

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800482A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800481A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (de)	1967-06-08	1972-04-25	Siemens Ag	Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens
GB2064336B (en)	1979-12-06	1984-03-14	Glaxo Group Ltd	Device for dispensing medicaments
DE3274065D1 (de)	1981-07-08	1986-12-11	Draco Ab	Powder inhalator
ES286422Y (es)	1982-10-08	1986-09-16	Glaxo Group Limited	Dispositivo para administrar medicamentos a pacientes
GB2169265B (en)	1982-10-08	1987-08-12	Glaxo Group Ltd	Pack for medicament
AT396872B (de)	1985-07-30	1993-12-27	Glaxo Group Ltd	Gerät zur verabreichung von medikamenten in pulverform
IT1204826B (it)	1986-03-04	1989-03-10	Chiesi Farma Spa	Composizioni farmaceutiche per inalazione
GB8923590D0 (en) *	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
GB9000304D0 (en) *	1990-01-06	1990-03-07	Pfizer Ltd	Muscarinic receptor antagonists
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
DE4108393A1 (de) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
JP3294961B2 (ja) *	1993-12-10	2002-06-24	杏林製薬株式会社	新規イミダゾール誘導体及びその製造法
JPH08291141A (ja) *	1995-04-21	1996-11-05	Kotobuki Seiyaku Kk	ジフェニル酢酸誘導体及びその製造法
JPH0920758A (ja) *	1995-07-06	1997-01-21	Kyorin Pharmaceut Co Ltd	新規環状ジアミン誘導体及びその製造法
AU5790598A (en) *	1996-12-02	1998-06-29	Georgetown University	Tropane derivatives and method for their synthesis
US6248752B1 (en) *	1998-02-27	2001-06-19	Charles Duane Smith	Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) *	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
JP2005512974A (ja) *	2001-10-17	2005-05-12	ユセベソシエテアノニム	キヌクリジン誘導体、その調製方法、及びｍ２及び／又はｍ３ムスカリン受容体阻害剤としてのその使用
US6696462B2 (en)	2002-01-31	2004-02-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
DE10211700A1 (de) *	2002-03-16	2003-09-25	Boehringer Ingelheim Pharma	Neue Difurylglykolsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
TW200410951A (en)	2002-08-06	2004-07-01	Glaxo Group Ltd	M3 muscarinic acetylcholine receptor antagonists
EP1613307A4 (de) *	2003-04-07	2008-03-12	Glaxo Group Ltd	M sb 3 /sb muscarinische acetylcholin-rezeptor-antagonisten
TW200519108A (en) *	2003-07-17	2005-06-16	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
UY28417A1 (es)	2003-07-17	2005-02-28	Glaxo Group Ltd	Antagonistas de los receptores muscarinicos de la acetilcolina
PE20050711A1 (es) *	2003-07-17	2005-09-10	Glaxo Group Ltd	Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina
KR20080065318A (ko)	2003-10-14	2008-07-11	글락소 그룹 리미티드	무스카린성 아세틸콜린 수용체 길항제
TW200524577A (en) *	2003-11-04	2005-08-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
ES2329586T3 (es)	2003-11-21	2009-11-27	Theravance, Inc.	Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
US20090258858A1 (en)	2004-10-29	2009-10-15	Jakob Busch-Petersen	Muscarinic acetylcholine receptor antagonists
WO2006055553A2 (en)	2004-11-15	2006-05-26	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
JP2008520573A (ja)	2004-11-15	2008-06-19	グラクソグループリミテッド	新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
PE20061162A1 (es)	2004-12-06	2006-10-14	Smithkline Beecham Corp	Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
PE20060826A1 (es)	2004-12-06	2006-10-08	Smithkline Beecham Corp	Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
WO2006065788A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Novel muscarinic acetylcholine receptor antagonists
WO2006065755A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetycholine receptor antagonists
WO2007018514A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2007016639A2 (en)	2005-08-02	2007-02-08	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
EP1937230A4 (de)	2005-08-02	2009-08-26	Glaxo Group Ltd	M3-muscarinische acetylcholin-rezeptor-antagonisten
WO2007022351A2 (en)	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists

2004
- 2004-10-12 KR KR1020087016101A patent/KR20080065318A/ko not_active Ceased
- 2004-10-12 DK DK04794886.4T patent/DK1677795T3/da active
- 2004-10-12 CN CNA2008100092900A patent/CN101230062A/zh active Pending
- 2004-10-12 US US10/575,839 patent/US7276521B2/en not_active Expired - Fee Related
- 2004-10-12 NZ NZ556424A patent/NZ556424A/en not_active IP Right Cessation
- 2004-10-12 OA OA1200600122A patent/OA13316A/en unknown
- 2004-10-12 PL PL04794886T patent/PL1677795T3/pl unknown
- 2004-10-12 TW TW093130797A patent/TWI409060B/zh not_active IP Right Cessation
- 2004-10-12 AR ARP040103693A patent/AR046103A1/es not_active Application Discontinuation
- 2004-10-12 PE PE2004000982A patent/PE20050963A1/es not_active Application Discontinuation
- 2004-10-12 AP AP2007004238A patent/AP2007004238A0/xx unknown
- 2004-10-12 EA EA200702619A patent/EA013689B1/ru not_active IP Right Cessation
- 2004-10-12 AP AP2007004239A patent/AP2007004239A0/xx unknown
- 2004-10-12 SG SG200807641-6A patent/SG147436A1/en unknown
- 2004-10-12 BR BRPI0415361-8A patent/BRPI0415361A/pt not_active Application Discontinuation
- 2004-10-12 UA UAA200604113A patent/UA87473C2/ru unknown
- 2004-10-12 WO PCT/US2004/033638 patent/WO2005037280A1/en not_active Ceased
- 2004-10-12 PT PT04794886T patent/PT1677795E/pt unknown
- 2004-10-12 MX MXPA06004244A patent/MXPA06004244A/es active IP Right Grant
- 2004-10-12 EA EA200702617A patent/EA013435B1/ru not_active IP Right Cessation
- 2004-10-12 JP JP2006535591A patent/JP2007508390A/ja active Pending
- 2004-10-12 UA UAA200900439A patent/UA89734C2/ru unknown
- 2004-10-12 ES ES04794886T patent/ES2358673T3/es not_active Expired - Lifetime
- 2004-10-12 NZ NZ546312A patent/NZ546312A/en not_active IP Right Cessation
- 2004-10-12 DE DE602004030930T patent/DE602004030930D1/de not_active Expired - Lifetime
- 2004-10-12 KR KR1020087016103A patent/KR20080067023A/ko not_active Ceased
- 2004-10-12 EP EP04794886A patent/EP1677795B1/de not_active Expired - Lifetime
- 2004-10-12 EA EA200600773A patent/EA200600773A1/ru not_active IP Right Cessation
- 2004-10-12 HR HR20110232T patent/HRP20110232T1/hr unknown
- 2004-10-12 CN CNA2004800372668A patent/CN1893948A/zh active Pending
- 2004-10-12 CN CNA2008100092898A patent/CN101230061A/zh active Pending
- 2004-10-12 AT AT04794886T patent/ATE494285T1/de active
- 2004-10-12 AP AP2006003566A patent/AP1828A/xx active
- 2004-10-12 KR KR1020067007082A patent/KR20060106821A/ko not_active Ceased
- 2004-10-12 CA CA2542657A patent/CA2542657C/en not_active Expired - Fee Related
- 2004-10-12 SI SI200431631T patent/SI1677795T1/sl unknown
- 2004-10-12 TW TW096137867A patent/TW200811171A/zh unknown
- 2004-10-12 MY MYPI20044177A patent/MY143366A/en unknown
- 2004-10-12 AU AU2004281724A patent/AU2004281724B2/en not_active Ceased
- 2004-10-12 TW TW096137868A patent/TW200811172A/zh unknown
2006
- 2006-03-31 EC EC2006006468A patent/ECSP066468A/es unknown
- 2006-04-06 IL IL174843A patent/IL174843A0/en unknown
- 2006-04-25 MA MA28964A patent/MA28110A1/fr unknown
- 2006-05-05 IS IS8441A patent/IS2918B/is unknown
- 2006-05-08 NO NO20062042A patent/NO20062042L/no not_active Application Discontinuation
2007
- 2007-06-21 US US11/766,371 patent/US7576096B2/en not_active Expired - Fee Related
- 2007-06-21 US US11/766,318 patent/US7579361B2/en not_active Expired - Fee Related
- 2007-08-02 JP JP2007201718A patent/JP4796552B2/ja not_active Expired - Fee Related
- 2007-08-02 JP JP2007201719A patent/JP2007314567A/ja active Pending
- 2007-12-13 IL IL188112A patent/IL188112A/en not_active IP Right Cessation
2011
- 2011-03-30 CY CY20111100339T patent/CY1111364T1/el unknown
- 2011-05-16 JP JP2011109756A patent/JP5450509B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL1677795T3 (pl)	2011-05-31
EA009899B1 (ru)	2008-04-28
JP2007314567A (ja)	2007-12-06
JP2007508390A (ja)	2007-04-05
AR046103A1 (es)	2005-11-23
PE20050963A1 (es)	2006-01-11
IL174843A0 (en)	2006-08-20
TW200811171A (en)	2008-03-01
NZ546312A (en)	2008-09-26
JP2007277276A (ja)	2007-10-25
DE602004030930D1 (de)	2011-02-17
EA013689B1 (ru)	2010-06-30
CA2542657A1 (en)	2005-04-28
UA87473C2 (en)	2009-07-27
CA2542657C (en)	2011-03-01
CN1893948A (zh)	2007-01-10
JP2011162556A (ja)	2011-08-25
TW200811172A (en)	2008-03-01
JP5450509B2 (ja)	2014-03-26
IS8441A (is)	2006-05-05
MXPA06004244A (es)	2006-06-28
SG147436A1 (en)	2008-11-28
HRP20110232T1 (hr)	2011-05-31
OA13316A (en)	2007-04-13
MY143366A (en)	2011-04-29
KR20060106821A (ko)	2006-10-12
EP1677795A1 (de)	2006-07-12
EA013435B1 (ru)	2010-04-30
IL188112A (en)	2012-10-31
CN101230061A (zh)	2008-07-30
US20070238752A1 (en)	2007-10-11
EP1677795B1 (de)	2011-01-05
ECSP066468A (es)	2006-11-16
ATE494285T1 (de)	2011-01-15
CN101230062A (zh)	2008-07-30
IL188112A0 (en)	2008-03-20
NZ556424A (en)	2008-12-24
AP2007004238A0 (en)	2007-12-31
US7276521B2 (en)	2007-10-02
TW200522933A (en)	2005-07-16
UA89734C2 (en)	2010-02-25
KR20080067023A (ko)	2008-07-17
BRPI0415361A (pt)	2006-12-12
US7579361B2 (en)	2009-08-25
AP1828A (en)	2008-02-13
SI1677795T1 (sl)	2011-04-29
US20070105895A1 (en)	2007-05-10
MA28110A1 (fr)	2006-08-01
EP1677795A4 (de)	2006-12-27
PT1677795E (pt)	2011-04-01
EA200600773A1 (ru)	2008-04-28
EA200702619A1 (ru)	2008-04-28
US20070244150A1 (en)	2007-10-18
AU2004281724A1 (en)	2005-04-28
WO2005037280A1 (en)	2005-04-28
AP2006003566A0 (en)	2006-04-30
AU2004281724B2 (en)	2010-07-15
ES2358673T3 (es)	2011-05-12
EA200702617A1 (ru)	2008-04-28
IS2918B (is)	2015-01-15
JP4796552B2 (ja)	2011-10-19
DK1677795T3 (da)	2011-04-18
TWI409060B (zh)	2013-09-21
US7576096B2 (en)	2009-08-18
NO20062042L (no)	2006-05-08
CY1111364T1 (el)	2015-08-05
KR20080065318A (ko)	2008-07-11

Publication	Publication Date	Title
AP1828A (en)	2008-02-13	Muscarinic Acetycholine receptor antagonists
AU2003261392A8 (en)	2004-02-23	M3muscarinic acetylcholine receptor antagonists
PL1638969T3 (pl)	2009-04-30	Antagoniści receptora CGRP
SI1682142T1 (sl)	2012-10-30	Antagonisti M3 muskarinskega acetilholinskega receptorja
AU2003301851A1 (en)	2004-06-07	Azacyclic compounds as orexin receptor antagonist
EP1648460A4 (de)	2009-04-01	Antagonisten des muskarinen acetylcholinrezeptors
IL172911A0 (en)	2006-06-11	Muscarinic acetylcholine receptor antagonists
IL172912A0 (en)	2006-06-11	Muscarinic acetylcholine receptor antagonists
EP1613307A4 (de)	2008-03-12	M sb 3 /sb muscarinische acetylcholin-rezeptor-antagonisten
IL174846A0 (en)	2006-08-20	Muscarinic acetylcholine receptor antagonists
PL370799A1 (en)	2005-05-30	Aminotetralin derivatives as muscarinic receptor antagonists
AU2002347552A1 (en)	2004-07-14	1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
GB0203412D0 (en)	2002-04-03	5-HT 2B receptor antagonists
SG131946A1 (en)	2007-05-28	Ccr3 receptor antagonists
AU2003267802A1 (en)	2004-05-25	Quaternary ammonium compounds as muscarinic receptor antagonists
IL173337A0 (en)	2006-06-11	Receptor
GB0302094D0 (en)	2003-02-26	EP4 receptor antagonists
HK1092357A (en)	2007-02-09	Muscarinic acetycholine receptor antagonists
AU2003249621A8 (en)	2003-12-12	Hemipteran muscarinic receptor
GB0321998D0 (en)	2003-10-22	Receptor
HK1089662A (en)	2006-12-08	Muscarinic acetylcholine receptor antagonists
HK1092355A (en)	2007-02-09	Muscarinic acetylcholine receptor antagonists
HK1089664A (en)	2006-12-08	Muscarinic acetylcholine receptor antagonists
HK1089663A (en)	2006-12-08	Muscarinic acetylcholine receptor antagonists
HK1107979A (en)	2008-04-25	Muscarinic receptor antagonists